Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | Linsitinib | 0.0033113 | uM | 9 | 1250.00 | 684.27 | 1966.00 | 1721.75 | 1.1419 | 1.2096 |
| BT-20 | Linsitinib | 3.1623 | uM | 9 | 1250.00 | 684.27 | 1791.00 | 1721.75 | 1.0402 | 1.0601 |
| BT-20 | Erlotinib | 0.0033113 | uM | 9 | 1250.00 | 684.27 | 1812.00 | 1721.75 | 1.0524 | 1.0782 |
| BT-20 | Lapatinib | 1 | uM | 9 | 1250.00 | 684.27 | 1657.00 | 1721.75 | 0.9624 | 0.9432 |
| BT-20 | 0 | uM | 9 | 1250.00 | 684.27 | 1784.00 | 1721.75 | 1.0362 | 1.0541 | |
| BT-20 | 0 | uM | 9 | 2500.00 | 1434.95 | 4045.00 | 4437.75 | 0.9115 | 0.8894 | |
| BT-20 | Linsitinib | 0.1 | uM | 9 | 2500.00 | 1434.95 | 4205.00 | 4437.75 | 0.9476 | 0.9349 |
| BT-20 | Lapatinib | 3.1623 | uM | 9 | 2500.00 | 1434.95 | 3228.00 | 4437.75 | 0.7274 | 0.6450 |
| BT-20 | Linsitinib | 10 | uM | 9 | 2500.00 | 1434.95 | 3318.00 | 4437.75 | 0.7477 | 0.6730 |
| BT-20 | Erlotinib | 0.1 | uM | 9 | 2500.00 | 1434.95 | 4595.00 | 4437.75 | 1.0354 | 1.0432 |
| BT-20 | Erlotinib | 19.9526 | uM | 9 | 2500.00 | 1434.95 | 2599.00 | 4437.75 | 0.5857 | 0.4401 |
| BT-20 | Erlotinib | 1 | uM | 9 | 2500.00 | 1434.95 | 3850.00 | 4437.75 | 0.8676 | 0.8329 |
| BT-20 | 17-AAG | 0.0031623 | uM | 9 | 2500.00 | 1434.95 | 4420.00 | 4437.75 | 0.9960 | 0.9951 |
| BT-20 | 0 | uM | 9 | 2500.00 | 1434.95 | 4585.00 | 4437.75 | 1.0332 | 1.0405 | |
| BT-20 | Linsitinib | 1 | uM | 9 | 2500.00 | 1434.95 | 4343.00 | 4437.75 | 0.9787 | 0.9737 |
| BT-20 | Erlotinib | 0.031623 | uM | 9 | 2500.00 | 1434.95 | 4762.00 | 4437.75 | 1.0731 | 1.0885 |
| BT-20 | Lapatinib | 0.31623 | uM | 9 | 2500.00 | 1434.95 | 4860.00 | 4437.75 | 1.0951 | 1.1148 |
| BT-20 | 17-AAG | 0.0001 | uM | 9 | 2500.00 | 1434.95 | 4443.00 | 4437.75 | 1.0012 | 1.0015 |
| BT-20 | 0 | uM | 9 | 2500.00 | 1434.95 | 4830.00 | 4437.75 | 1.0884 | 1.1068 | |
| BT-20 | 17-AAG | 0.000302 | uM | 9 | 2500.00 | 1434.95 | 4876.00 | 4437.75 | 1.0988 | 1.1190 |
| BT-20 | Erlotinib | 10 | uM | 9 | 2500.00 | 1434.95 | 2987.00 | 4437.75 | 0.6731 | 0.5685 |
| BT-20 | 17-AAG | 0.001 | uM | 9 | 2500.00 | 1434.95 | 4446.00 | 4437.75 | 1.0019 | 1.0023 |
| BT-20 | Lapatinib | 10 | uM | 9 | 2500.00 | 1434.95 | 1911.00 | 4437.75 | 0.4306 | 0.1923 |
| BT-20 | 0 | uM | 9 | 2500.00 | 1434.95 | 4781.00 | 4437.75 | 1.0773 | 1.0936 | |
| BT-20 | 0 | uM | 9 | 2500.00 | 1434.95 | 4580.00 | 4437.75 | 1.0321 | 1.0391 |